IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

An2 Thereapeutics Inc

CUSIP: 373261056 | 1 institutional holders

Quarters

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2026

Aldebaran Capital, LLC367,435
1.3% of portfolio›$1.8M
StyleTurnoverLocationFiled
Aldebaran Capital, LLC
367,435$1.8M1.3%ValueLowCarmel, IN2026-08-14